Small-Molecule Drugs See Demand Growth, Says Aruvian's R'search in Its New Report Available at MarketPublishers.com16 Aug 2016 • by Natalie Aster
LONDON – A focus on the generic drugs industry has been growing over the recent years from pole to pole. This is a result of the patient expiry of some leading drugs and upcoming expiries of other blockbuster drugs.
At present, the small-molecule generic drugs are witnessing growth of the demand. The ‘pro-generics’ legislation is also on the rise. In the meantime, the number of M&A in this space is increasing, and popularity of strategic alliances is also growing.
Pricing and reimbursement of generic drugs across major marketы represent an important aspect of the global marketplace. Some of such marketplaces comprise: China, Romania, Germany, Norway, the UK, Sweden, Hungary, and more.
Top companies involved in this space include: Apotex, Lupin, Allergan, Sanofi, to name a few.
New research report “Analyzing the Global Generics Industry 2016” worked out by Aruvian's R'search offers an up-close look at the global generic drugs market. The study covers historical development of this industry. It contains an all-round overview of the industry, an analysis of its value and volume and R&D activities in this space.
The report covers patent expires and contains Porter’s five forces analysis. The research study casts light on the regulatory framework along with its impact on the industry in the USA, Europe and Japan.
It delves deep into trends and challenges of this marketplace. The research report throws light on industry strategies and scrutinizes major markets like Brazil, Canada, France, India, etc. The study contains details on pricing and reimbursement of generics. It gives a detailed industry forecast and focuses on top companies, as well.
- in-depth analysis of the global market;
- investigation of the regulatory framework;
- details on trends and challenges;
- information on industry strategies;
- examination of major marketplaces;
- company profiles;
- forecast figures;
- and more.
More new research reports by Aruvian's R'search are available at its page.